Mitochondrial diseases caused by toxic compound accumulation: From etiopathology to therapeutic approaches

EMBO Molecular Medicine

Volumn 7, Issue 10, 2015, Pages 1257-1266

  Di Meo, Ivano ^a   Lamperti, Costanza ^a   Tiranti, Valeria ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Mitochondrial diseases; OXPHOS; Sulfide catabolism; Therapeutic approaches; Thymidine deoxyuridine catabolism

Indexed keywords

ACETYLCYSTEINE; CYTOCHROME C OXIDASE; DEOXYCYTIDINE; DEOXYRIBONUCLEOSIDE; DEOXYURIDINE; HYDROGEN SULFIDE; LENTIVIRUS VECTOR; METRONIDAZOLE; MITOCHONDRIAL DNA; PARVOVIRUS VECTOR; TETRAHYDROURIDINE; THYMIDINE; ETHE1 PROTEIN, HUMAN; MITOCHONDRIAL PROTEIN; NUCLEOCYTOPLASMIC TRANSPORT PROTEIN; THYMIDINE PHOSPHORYLASE; TYMP PROTEIN, HUMAN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANAEROBIC INFECTION; CELL PROTECTION; DIARRHEA; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA REPLICATION; ETHYLMALONIC ENCEPHALOPATHY; ETHYLMALONIC ENCEPHALOPATHY 1 GENE; GENE; GENE MUTATION; HUMAN; LIVER TRANSPLANTATION; LONG TERM POTENTIATION; LOSS OF FUNCTION MUTATION; MISSENSE MUTATION; MITOCHONDRIAL DNA DEPLETION; MNGIE SYNDROME; NONHUMAN; OFF LABEL DRUG USE; OXIDATIVE PHOSPHORYLATION; POINT MUTATION; PRIORITY JOURNAL; PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY; PYRIMIDINE METABOLISM; REVIEW; TYMP GENE; VIRAL GENE THERAPY; BRAIN DISEASES, METABOLIC, INBORN; GENETICS; INTESTINAL PSEUDO-OBSTRUCTION; MITOCHONDRIAL DISEASES; MITOCHONDRIAL ENCEPHALOMYOPATHIES; MUTATION; PATHOPHYSIOLOGY; PURPURA;

BRAIN DISEASES, METABOLIC, INBORN; HUMANS; INTESTINAL PSEUDO-OBSTRUCTION; MITOCHONDRIAL DISEASES; MITOCHONDRIAL ENCEPHALOMYOPATHIES; MITOCHONDRIAL PROTEINS; MUTATION; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; PURPURA; THYMIDINE PHOSPHORYLASE;

EID: 84942826843     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.15252/emmm.201505040     Document Type: Review

References (72)

1. Abe K, Kimura H (1996) The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 16: 1066-1071
2. Balasubramaniam S, Duley JA, Christodoulou J (2014) Inborn errors of pyrimidine metabolism: clinical update and therapy. J Inherit Metab Dis 37: 687-698
3. Berg M, Tymoczko JL, Stryer L (2002) Biosynthesis of nucleotides. In Biochemistry, Berg M, Tymoczko JL, Stryer L (eds), pp 602-626. New York: Freeman
4. Bogenhagen D, Clayton DA (1976) Thymidylate nucleotide supply for mitochondrial DNA synthesis in mouse L-cells. Effect of 5-fluoro-deoxyuridine and methotrexate in thymidine kinase plus and thymidine kinase minus cells. J Biol Chem 251: 2938-2944
5. Boschetti E, D'Alessandro R, Bianco F, Carelli V, Cenacchi G, Pinna AD, Del Gaudio M, Rinaldi R, Stanghellini V, Pironi L et al (2014) Liver as a source for thymidine phosphorylase replacement in mitochondrial neurogastrointestinal encephalomyopathy. PLoS ONE 9: e96692
6. Bucci M, Papapetropoulos A, Vellecco V, Zhou Z, Pyriochou A, Roussos C, Roviezzo F, Brancaleone V, Cirino G (2010) Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity. Arterioscler Thromb Vasc Biol 30: 1998-2004
7. Burlina A, Zacchello F, Dionisi-Vici C, Bertini E, Sabetta G, Bennet MJ, Hale DE, Schmidt-Sommerfeld E, Rinaldo P (1991) New clinical phenotype of branched-chain acyl-CoA oxidation defect. Lancet 338: 1522-1523
8. Cámara Y, González-Vioque E, Scarpelli M, Torres-Torronteras J, Caballero A, Hirano M, Martí R (2014) Administration of deoxyribonucleosides or inhibition of their catabolism as a pharmacological approach for mitochondrial DNA depletion syndrome. Hum Mol Genet 23: 2459-2467
9. Coleman JE (1967) Mechanism of action of carbonic anhydrase: substrate, sulfonamide, and anion binding. J Biol Chem 242: 5212-5219
10. Delicou S, Kitra-Roussou V, Peristeri J, Goussetis E, Vessalas G, Rigatou E, Psychou F, Salavoura K, Grafakos S (2007) Successful HLA-identical hematopoietic stem cell transplantation in a patient with purine nucleoside phosphorylase deficiency. Pedriat Transplant 11: 799-803
11. Di Meo I, Auricchio A, Lamperti C, Burlina A, Viscomi C, Zeviani M (2012) Effective AAV-mediated gene therapy in a mouse model of ethylmalonic encephalopathy. EMBO Mol Med 4: 1008-1014
12. Di Meo I, Fagiolari G, Prelle A, Viscomi C, Zeviani M, Tiranti V (2011) Chronic exposure to sulfide causes accelerated degradation of cytochrome c oxidase in ethylmalonic encephalopathy. Antioxid Redox Signal 15: 353-362
13. Drousiotou A, DiMeo I, Mineri R, Georgiou T, Stylianidou G, Tiranti V (2011) Ethylmalonic encephalopathy: application of improved biochemical and molecular diagnostic approaches. Clin Genet 79: 385-390
14. Elsey DJ, Fowkes RC, Baxter GF (2010) Regulation of cardio- vascular cell function by hydrogen sulfide (H2S). Cell Biochem Funct 28: 95-106
15. Ferdinandy P, Schulz R, Baxter GF (2007) Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 59: 418-458
16. Giordano C, Viscomi C, Orlandi M, Papoff P, Spalice A, Burlina A, Di Meo I, Tiranti V, Leuzzi V, d'Amati G et al (2012) Morphologic evidence of diffuse vascular damage in human and in the experimental model of ethylmalonic encephalopathy. J Inherit Metab Dis 35: 451-458
17. Grieger JC, Samulski RJ (2005) Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications. Adv Biochem Eng Biotechnol 99: 119-145
18. Halter J, Schüpbach WM, Casali C, Elhasid R, Fay K, Hammans S, Illa I, Kappeler L, Krähenbühl S, Lehmann T et al (2011) Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach. Bone Marrow Transplant 46: 330-337
19. Hildebrandt TM, Di Meo I, Zeviani M, Viscomi C, Braun HP (2013) Proteome adaptations in Ethe1-deficient mice indicate a role in lipid catabolism and cytoskeleton organization via post-translational protein modifications. Biosci Rep 33: 575-584
20. Hildebrandt TM, Grieshaber MK (2008) Three enzymatic activities catalyze the oxidation of sulfide to thiosulfate in mammalian and invertebrate mitochondria. FEBS J 275: 3352-3361
21. Hill BC, Woon TC, Nicholls P, Peterson J, Greenwood C, Thomson AJ (1984) Interactions of sulphide and other ligands with cytochrome c oxidase. An electron-paramagnetic-resonance study. Biochem J 224: 591-600
22. Hine C, Harputlugil E, Zhang Y, Ruckenstuhl C, Lee BC, Brace L, Longchamp A, Treviño-Villarreal JH, Mejia P, Ozaki CK et al (2015) Endogenous hydrogen sulfide production is essential for dietary restriction benefits. Cell 160: 132-144
23. Hirano M, Garone C, Quinzii CM (2012) CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders. Biochim Biophys Acta 1820: 625-631
24. Hirano M, Martí R, Casali C, Tadesse S, Uldrick T, Fine B, Escolar DM, Valentino ML, Nishino I, Hesdorffer C et al (2006) Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 67: 1458-1460
25. Hirano M, Martí R, Spinazzola A, Nishino I, Nishigaki Y (2004) Thymidine phosphorylase deficiency causes MNGIE: an autosomal recessive mitochondrial disorder. Nucleos Nucleot Nucl 23: 1217-1225
26. Hirano M, Silvestri G, Blake DM, Lombes A, Minetti C, Bonilla E, Hays AP, Lovelace RE, Butler I, Bertorini TE et al (1994) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44: 721-727
27. Jackson MR, Melideo SL, Jorns MS (2012) Human sulfide: quinone oxidoreductase catalyzes the first step in hydrogen sulfide metabolism and produces a sulfane sulfur metabolite. Biochemistry 51: 6804-6815
28. Johansson M, Karlsson A (1997) Cloning of the cDNA and chromosome localization of the gene for human thymidine kinase 2. J Biol Chem 272: 8454-8458
29. Kamoun P (2004) Endogenous production of hydrogen sulfide. Amino Acids 26: 243-254
30. Kimura Y, Kimura H (2004) Hydrogen sulfide protects neurons from oxidative stress. FASEB J 18: 1165-1167
31. 2 receptors. Respir Physiol 32: 355-367
32. Lara MC, Valentino ML, Torres-Torronteras J, Hirano M, Martí R (2007) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): biochemical features and therapeutic approaches. Biosci Rep 27: 151-163
33. Lara MC, Weiss B, Illa I, Madoz P, Massuet L, Andreu AL, Valentino ML, Anikster Y, Hirano M, Martí R (2006) Infusion of platelets transiently reduces nucleoside overload in MNGIE. Biosci Rep 27: 151-163
34. López LC, Akman HO, García-Cazorla A, Dorado B, Martí R, Nishino I, Tadesse S, Pizzorno G, Shungu D, Bonilla E et al (2009) Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice. Hum Mol Genet 18: 714-722
35. Lopez-Contreras AJ, Specks J, Barlow JH, Ambrogio C, Desler C, Vikingsson S, Rodrigo-Perez S, Green H, Rasmussen LJ, Murga M et al (2015) Increased Rrm2 gene dosage reduces fragile site breakage and prolongs survival of ATR mutant mice. Genes Dev 29: 690-695
36. Marí M, Morales A, Colell A, García-Ruiz C, Fernandez-Checa JC (2009) Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal 11: 2685-2700
37. Martí R, Nishigaki Y, Vilá MR, Hirano M (2003) Alteration of nucleotide metabolism: a new mechanism for mitochondrial disorders. Clin Chem Lab Med 41: 845-851
38. Matsukawa K, Moriyama A, Kawai Y, Asai K, Kato T (1996) Tissue distribution of human gliostatin/platelet-derived endothelial cell growth factor (PD-ECGF) and its drug-induced expression. Biochim Biophys Acta 1314: 71-82
39. Mineri R, Rimoldi M, Burlina AB, Koskull S, Perletti C, Heese B, von Döbeln U, Mereghetti P, Di Meo I, Invernizzi F et al (2008) Identification of new mutations in the ETHE1 gene in a cohort of 14 patients presenting with ethylmalonic encephalopathy. J Med Genet 45: 473-478
40. Moran NF, Bain MD, Muqit MM, Bax BE (2008) Carrier erythrocyte entrapped thymidine phosphorylase therapy for MNGIE. Neurology 71: 686-688
41. Nagai Y, Tsugane M, Oka J, Kimura H (2004) Hydrogen sulfide induces calcium waves in astrocytes. FASEB J 18: 557-559
42. Nathwani AC, Tuddenham EG, Rangarajan S, Rosales C, McIntosh J, Linch DC, Chowdary P, Riddell A, Pie AJ, Harrington C et al (2011) Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Eng J Med 365: 2357-2365
43. Nishigaki Y, Martí R, Copeland WC, Hirano M (2003) Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. J Clin Invest 111: 1913-1921
44. Nishino I, Spinazzola A, Hirano M (1999) Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283: 689-692
45. Nishino I, Spinazzola A, Papadimitriou A, Hammans S, Steiner I, Hahn CD, Connolly AM, Verloes A, Guimarães J, Maillard I et al (2000) Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol 47: 792-800
46. Nowaczyk MJ, Lehotay DC, Platt BA, Fisher L, Tan R, Phillips H, Clarke JT (1998) Ethylmalonic and methylsuccinic aciduria in ethylmalonic encephalopathy arise from abnormal isoleucine metabolism. Metabolism 47: 836-839
47. Oh GS, Pae HO, Lee BS, Kim BN, Kim JM, Kim HR, Jeon SB, Jeon WK, Chae HJ, Chung HT (2006) Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kB via heme oxygenase-1 expression in RAW2647 macrophages stimulated with lipopolysaccharide. Free Radic Biol Med 41: 106-119
48. Okamura K, Santa T, Nagae K, Omae T (1976) Congenital oculoskeletal myopathy with abnormal muscle and liver mitochondria. J Neurol Sci 27: 79-91
49. Pedersen CB, Bross P, Winter VS, Corydon TJ, Bolund L, Bartlett K, Vockley J, Gregersen N (2003) Misfolding, degradation, and aggregation of variant proteins. The molecular pathogenesis of short chain acyl-CoA dehydrogenase (SCAD) deficiency. J Biol Chem 278: 47449-47458
50. Peedikayil MC, Kagevi EI, Abufarhaneh E, Alsayed MD, Alzahrani HA (2015) Mitochondrial neurogastrointestinal encephalomyopathy treated with stem cell transplantation: a case report and review of literature. Hematol Oncol Stem Cell Ther 8: 85-90
51. Pettinati I, Brem J, McDonough MA, Schofield CJ (2015) Crystal structure of human persulfide dioxygenase: structural basis of ethylmalonic encephalopathy. Hum Mol Genet 24: 2458-2469
52. Pontarin G, Ferraro P, Valentino ML, Hirano M, Reichard P, Bianchi V (2006) Mitochondrial DNA depletion and thymidine phosphate pool dynamics in a cellular model of mitochondrial neurogastrointestinal encephalomyopathy. J Biol Chem 281: 22720-22728
53. Pontarin G, Gallinaro L, Ferraro P, Reichard P, Bianchi V (2003) Origins of mitochondrial thymidine triphosphate: dynamic relations to cytosolic pools. Proc Natl Acad Sci USA 100: 12159-12164
54. Powell MA, Somero GN (1986) Hydrogen sulfide oxidation is coupled to oxidative phosphorylation in mitochondria of Solemya reidi. Science 233: 563-566
55. Qingyou Z, Junbao D, Weijin Z, Hui Y, Chaoshu T, Chunyu Z (2004) Impact of hydrogen sulfide on carbon monoxide/heme oxygenase pathway in the pathogenesis of hypoxic pulmonary hypertension. Biochem Biophys Res Commun 317: 30-37
56. Rowan FE, Docherty NG, Coffey JC, O'Connell PR (2009) Sulphate-reducing bacteria and hydrogen sulphide in the aetiology of ulcerative colitis. Br J Surg 96: 151-158
57. Samuelson J (1999) Why metronidazole is active against both bacteria and parasites. Antimicrob Agents Chemother 43: 1533-1541
58. Schoors S, Bruning U, Missiaen R, Queiroz KC, Borgers G, Elia I, Zecchin A, Cantelmo AR, Christen S, Goveia J et al (2015) Fatty acid carbon is essential for dNTP synthesis in endothelial cells. Nature 520: 192-197
59. Tiranti V, Briem E, Lamantea E, Mineri R, Papaleo E, De Gioia L, Forlani F, Rinaldo P, Dickson P, Abu-Libdeh B et al (2006) ETHE1 mutations are specific to ethylmalonic encephalopathy. J Med Genet 43: 340-346
60. Tiranti V, D'Adamo P, Briem E, Ferrari G, Mineri R, Lamantea E, Mandel H, Balestri P, Garcia-Silva MT, Vollmer B et al (2004) Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet 74: 239-252
61. Tiranti V, Viscomi C, Hildebrandt T, Di Meo I, Mineri R, Tiveron C, Levitt MD, Prelle A, Fagiolari G, Rimoldi M et al (2009) Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. Nat Med 15: 200-205
62. Tiranti V, Zeviani M (2013) Altered sulfide (H(2)S) metabolism in ethylmalonic encephalopathy. Cold Spring Harb Perspect Biol 5: a011437
63. Torres-Torronteras J, Gómez A, Eixarch H, Palenzuela L, Pizzorno G, Hirano M, Andreu AL, Barquinero J, Martí R (2011) Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE. Gene Ther 18:795-806
64. Torres-Torronteras J, Viscomi C, Cabrera-Pérez R, Cámara Y, Di Meo I, Barquinero J, Auricchio A, Pizzorno G, Hirano M, Zeviani M et al (2014) Gene therapy using a liver-targeted AAV vector restores nucleoside and nucleotide homeostasis in a murine model of MNGIE. Mol Ther 23: 2459-2467
65. Viscomi C, Burlina AB, Dweikat I, Savoiardo M, Lamperti C, Hildebrandt T, Tiranti V, Zeviani M (2010) Combined treatment with oral metronidazole and N-ace- tylcysteine is effective in ethylmalonic encephalopathy. Nat Med 16: 869-871
66. Wallace DC (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39: 359-407
67. Webster DR, Becroft DM, van Gennip A, Van Kuilenberg A (2001) Hereditary orotic aciduria and other disorders. In The Metabolic and Molecular Bases of Inherited Disease, 8th edn. Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B (eds), pp 2663-2702. New York: McGraw-Hill
68. Whiteman M, Armstrong JS, Chu SH, Jia-Ling S, Wong BS, Cheung NS, Halliwell B, Moore PK (2004) The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite "scavenger?". J Neurochem 90: 765-768
69. Xu M, Wu YM, Li Q, Wang X, He RR (2008) Electrophysio- logical effects of hydrogen sulfide on pacemaker cells in sinoatrial nodes of rabbits. Sheng Li Xue Bao 60: 175-180
70. Yalamanchili C, Smith MD (2008) Acute hydrogen sulfide toxicity due to sewer gas exposure. Am J Emerg Med 26: 518.e5-7
71. Yang G, Sun X, Wang R (2004) Hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of mitogen-activated protein kinases and caspase-3. FASEB J 18: 1782-1784
72. Yavuz H, Ozel A, Christensen M, Christensen E, Schwartz M, Elmaci M, Vissing J (2007) Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis. Arch Neurol 64: 435-438